Search

Search Constraints

You searched for: Author/Creator Miyake, Yasuhiro

Search Results

2. A new monitoring tool CLIP test for progression of oxaliplatin‐induced peripheral neuropathy: A multicenter prospective study. Issue 5 (7th September 2020)

3. A prospective Phase II study to examine the relationship between quality of life and adverse events of first‐line chemotherapy plus cetuximab in patients with KRAS wild‐type unresectable metastatic colorectal cancer: QUACK trial. (26th July 2018)

4. Alteration of N‐glycan profiles in patients with chronic hepatitis and hepatocellular carcinoma. Issue 9 (13th January 2015)

5. Anti‐programmed cell death‐1 antibody as a new serological marker for type 1 autoimmune hepatitis. Issue 1 (January 2014)

6. Assessment of health‐related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C. Issue 2 (February 2014)

7. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C. Issue 3 (19th August 2015)

8. Autoantibody status and histological variables influence biochemical response to treatment and long‐term outcomes in Japanese patients with primary biliary cirrhosis. Issue 8 (11th December 2014)

9. Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer. Issue 1 (December 2015)

10. Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): A multicentre, randomised, controlled phase 3 trial. Issue 10 (July 2015)